Crohn’s & Colitis Congress™
Tweet
Sessions
Speakers
Exhibitors
Floor Plan
Buzz
Search
Sessions
(0)
View/Sort by
Tracks
|
Day
Details
Satellite Symposium: Fact or Fiction? Sorting Out Common Misconceptions About UC to Improve Patient Care
(
Room
Pinyon 7/8
)
19 Jan 18
6:00 AM
-
7:30 AM
Welcome
(
Room
Pinyon 4/5
)
19 Jan 18
7:45 AM
-
7:55 AM
Welcome & Opening Panel
(
Room
Pinyon 4/5
)
19 Jan 18
7:45 AM
-
8:20 AM
Concept and Findings of the Foundation’s Update to “Challenges in IBD”
(
Room
Pinyon 4/5
)
19 Jan 18
7:54 AM
-
8:20 AM
Keynote Research Presentation: Is Complicated IBD Genetically Defined?
(
Room
Pinyon 4/5
)
19 Jan 18
8:25 AM
-
8:45 AM
Keynote Clinical Presentation: Non-Responders to Current Biologics: What Treatments Are on the Horizon?
(
Room
Pinyon 4/5
)
19 Jan 18
8:45 AM
-
9:05 AM
10 - EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIED SHARED METHYLOMIC CONTRIBUTIONS TO SUSCEPTIBILITY AND PROGRESSION IN PEDIATRIC CROHN'S DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
9:05 AM
-
9:15 AM
11 - DELAYED ILEAL POUCH ANAL ANASTOMOSIS HAS A LOWER 30-DAY ADVERSE EVENT RATE: ANALYSIS FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM
(
Room
Pinyon 4/5
)
19 Jan 18
9:15 AM
-
9:25 AM
12 - HIGH PATIENT ACTIVATION IS ASSOCIATED WITH CLINICAL REMISSION IN A LONGITUDINAL ANALYSIS OF A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
9:25 AM
-
9:35 AM
Poster Presentations
19 Jan 18
10:00 AM
-
10:30 AM
Adolescent, Young Adults and Pregnant Patients with IBD
(
Room
Pinyon 3
)
19 Jan 18
10:30 AM
-
11:30 AM
Management of Perianal and Pouch Complications
(
Room
Bristlecone 3
)
19 Jan 18
10:30 AM
-
11:30 AM
The Multidisciplinary Care of the Complicated IBD Patient
(
Room
Pinyon 4/5
)
19 Jan 18
10:30 AM
-
11:30 AM
Adolescent, Young Adults and Pregnant Patients with IBD (repeated)
(
Room
Pinyon 3
)
19 Jan 18
11:30 AM
-
12:20 PM
Management of Perianal and Pouch Complications (repeated)
(
Room
Bristlecone 3
)
19 Jan 18
11:30 AM
-
12:20 PM
The Multidisciplinary Care of the Complicated IBD Patient (repeated)
(
Room
Pinyon 4/5
)
19 Jan 18
11:30 AM
-
12:20 PM
Satellite Symposium: IBD Nutrition Assessment, Intervention and Treatment
(
Room
Pinyon 1/2
)
19 Jan 18
12:35 PM
-
1:40 PM
Satellite Symposium: Vaccinations and IBD: Special Considerations and Preventive Measures to Improve Patient Outcomes
(
Room
Pinyon 7/8
)
19 Jan 18
12:35 PM
-
1:40 PM
Keynote Clinical Presentation: How to Incorporate New Therapies into Current Practice
(
Room
Pinyon 4/5
)
19 Jan 18
2:00 PM
-
2:20 PM
13 - REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
2:20 PM
-
2:30 PM
Keynote Research Presentation: Biomarkers for Precision Medicine
(
Room
Pinyon 4/5
)
19 Jan 18
2:30 PM
-
2:50 PM
14 - POST-HOC ANALYSIS OF TOFACITINIB CROHN’S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION
(
Room
Pinyon 4/5
)
19 Jan 18
2:50 PM
-
3:00 PM
Multidisciplinary Panel Review of Cases
(
Room
Pinyon 4/5
)
19 Jan 18
3:20 PM
-
4:10 PM
Poster Presentations
19 Jan 18
4:10 PM
-
4:40 PM
Challenges in Monitoring Response
(
Room
Pinyon 4/5
)
19 Jan 18
4:40 PM
-
5:20 PM
Predictors of Immune Response: How to Decide Which Therapy to Choose
(
Room
Pinyon 3
)
19 Jan 18
4:40 PM
-
4:55 PM
Proactive Therapeutic Drug Monitoring — For Whom and How
(
Room
Pinyon 4/5
)
19 Jan 18
4:40 PM
-
4:55 PM
Research That Will Guide Your Practice, Not Tomorrow, But Soon
(
Room
Pinyon 3
)
19 Jan 18
4:40 PM
-
5:20 PM
Asymptomatic but Ongoing Inflammation — What Now and Does Age Matter?
(
Room
Pinyon 4/5
)
19 Jan 18
4:55 PM
-
5:10 PM
Fecal Metabolomic Analysis: Ready for Clinical Use?
(
Room
Pinyon 3
)
19 Jan 18
4:55 PM
-
5:10 PM
P001 - #IBD: A WORD ASSOCIATION ANALYSIS OF TWEETS ABOUT INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P002 - 2-ACCETYL-4-TETRAHYDROXYBUTYL IMIDAZOLE AMELIORATES DEXTRAN SULFATE SODIUM-INDUCED COLITIS VIA SUPPRESSION OF SPHINGOSINE-1-PHOSPHATE LYASE
19 Jan 18
5:30 PM
-
7:00 PM
P003 - A COMPARISON OF THE MUCOSA-ASSOCIATED MICROBIAL COMMUNITY STRUCTURE BETWEEN INFLAMED AND NON-INFLAMED SITES IN PATIENTS WITH ULCERATIVE COLITIS
19 Jan 18
5:30 PM
-
7:00 PM
P004 - A DIET LOW IN RED AND PROCESSED MEATS DOES NOT REDUCE THE RATE OF CROHN’S DISEASE FLARES IN A RANDOMIZED CONTROLLED TRIAL: RESULTS OF THE FOOD AND CROHN’S DISEASE EXACERBATION STUDY (FACES)
19 Jan 18
5:30 PM
-
7:00 PM
P005 - A MUCOSAL AND CHEMOKINE LIGAND FOR THE LYMPHOCYTE CHEMOATTRACTANT RECEPTOR GPR15
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P006 - A NEW MODEL OF SPONTANEOUS INNATE IMMUNE MEDIATED COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P007 - QUALITATIVE STUDY OF THE EXPERIENCE OF ADULTS AND ADOLESCENTS WITH ULCERATIVE COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P008 - A QUALITATIVE STUDY OF THE PATIENT EXPERIENCE OF PAIN AND PAIN-RELATED FUNCTIONAL IMPACTS SPECIFIC TO CROHN’S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P009 - A RARE CASE OF A GASTRIC ABSCESS FISTULIZING TO THE DUODENUM IN CROHN’S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P010 - ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P011 - ADHERENT-INVASIVE ESCHERICHIA COLI UTILIZES SERINE CATABOLISM TO OUTCOMPETE ITS COMMENSAL COMPETITORS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P012 - ANTI-TNF DRUG ANTIBODY LEVELS CORRELATE WITH POST-SURGICAL RECURRENCE IN CROHN’S DISEASE (CD)
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P013 - APOPTOTIC ENTEROPATHY INDUCED BY THALIDOMIDE IN A PATIENT WITH REFRACTORY UPPER AND COLONIC CROHNS’ DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P014 - AVERAGE ANNUAL HEALTHCARE COSTS FOR PEDIATRIC AND ADULT PATIENTS WITH CROHN’S DISEASE OR ULCERATIVE COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P015 - BODY IMAGE DISSATISFACTION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P016 - CASE SERIES: IMMUNOTHERAPY-INDUCED LYMPHOCYTIC COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P017 - CD47 REGULATES CD11B-DEPENDENT NEUTROPHIL TRANSEPITHELIAL MIGRATION DURING INTESTINAL INFLAMMATION
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P018 - CLINICAL COURSE AND OUTCOMES OF INFLAMMATORY BOWEL DISEASE PATIENTS WHO UNDERWENT SOLID ORGAN TRANSPLANTATION IN KOREA
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P019 - CLINICAL EFFICACY OF ANTI-TNFA ANTIBODY TREATMENT IN PATIENTS WITH DEFINITE OR SUSPECTED INTESTINAL BEHCET DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P020 - COLONIC INHIBITION OF PHOSPHATASE AND TENZIN HOMOLOG (PATEN) INCREASES COLITOGENIC BACTERIA, INDUCING COLITIS IN IL10 DEFICIENT MICE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P021 - COMPLEMENTARY AND ALTERNATIVE MEDICINE IN INFLAMMATORY BOWEL DISEASE: WHERE'S THE DISCUSSION?
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P022 - CROHN’S DISEASE AND ACUTE B LYMPHOBLASTIC LEUKEMIA – COINCIDENCE OR ASSOCIATION?
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P023 - CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENT PERSPECTIVES ON PARTICIPATION IN IBD CLINICAL TRIALS
19 Jan 18
5:30 PM
-
7:00 PM
P024 - CROHN’S DISEASE MESSAGING ON TWITTER: WHO’S TALKING?
19 Jan 18
5:30 PM
-
7:00 PM
P025 - CYSTATHIONINE-GAMMA-LYASE REGULATES MACROPHAGE INTERLEUKIN-10 (IL-10) PRODUCTION IN COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P026 - DEVELOPMENT OF A PREFERENCE-WEIGHTED SYMPTOM SCALE FOR INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P027 - DIFFERENTIAL BINDING OF RBPJ AND CUX1 TO IBD CAUSAL SNP rs1887428 MODIFIES EXPRESSION OF JAK2
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P028 - DYSBIOSIS DRIVEN LUMINAL MALMETABOLISM INCREASES THE RISK OF C. DIFFICLILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P029 - ENDOCYTOSCOPIC FINDINGS PREDICT RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS DURING LONG-TERM FOLLOW-UP NO LESS THAN 5 YEARS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P030 - ENPP1 EXPRESSION IN GUT MUCOSAL EPITHELIA INFLUENCES BARRIER FUNCTION VIA THE ADENOSINE PATHWAY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P031 - ENTERIC GLIA SHARE CHARACTERISTICS WITH ANTIGEN PRESENTING CELLS AND MAY ALTER SERUM CHEMOKINE LEVELS DURING NEUROINFLAMMATION
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P032 - EPICERTIN ENHANCES INTESTINAL WOUND HEALING IN A MOUSE COLITIS MODEL AND HUMAN ULCERATIVE COLITIS COLON EXPLANTS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P033 - EPIGENETIC SILENCING OF SMAD7 CONTRIBUTES TO FIBROSIS IN STRICTURING CROHN’S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P034 - EXERCISE AS ADJUNCTIVE THERAPY IN INFLAMMATORY BOWEL DISEASE: AN EDUCATIONAL INTERVENTION CAN INCREASE PHYSICIAN AWARENESS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P035 - EXOGENOUS ADMINISTRATION OF IRISIN DURING CHRONIC TNBS-INDUCED GUT INFLAMMATION REVERSES INFLAMMATION-INDUCED ALTERATIONS IN BONE TURNOVER
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P036 - EXPLORING EARLY-RESPONSIVE PHARMACODYNAMIC BIOMARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD)
(
Room
Poster Session
)
19 Jan 18
5:30 PM
-
7:00 PM
P037 - FAECALIBACTERIUM IS INCREASED IN PATIENTS WITH CROHN’S DISEASE ON A LOW FIBER DIET
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P038 - FECAL MICROBIOTA TRANSPLANT (FMT) FOR IMMUNO-CHECKPOINT INHIBITOR-INDUCED COLITIS (ICI-C) IN A 50 YEAR OLD FEMALE WITH BLADDER CANCER
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P039 - FECAL miRNAs SHAPE THE INTESTINAL MICROBIOTA
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P040 - FIBROBLAST GROWTH FACTOR-INDUCIBLE 14 (FN14) SIGNALING MEDIATES CROHN’S DISEASE (CD)-LIKE ILEITIS IN SAMP MICE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P041 - GLIAL CONNEXIN-43 REGULATES NEURO-IMMUNE INTERACTIONS IN THE MOUSE COLON
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P042 - GREEN TEA EXTRACT, EGCG, INHIBITS DNMT-1, ER STRESS AND PREVENTS THE DEVELOPMENT OF INTESTINAL FIBROSIS IN MURINE CHRONIC TNBS-INDUCED COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P043 - HEALTHCARE SERVICE UTILIZATION AND COSTS OF CERTOLIZUMAB PEGOL VERSUS INFLIXIMAB TREATMENT IN PATIENTS WITH CROHN’S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P044 - HIF1A IS A SWITCH IN THE PRO- VS ANTI-INFLAMMATORY FOXP3 GENE CIRCUITRY NETWORKS IMPLICATED IN INFLAMMATORY BOWEL DISEASE.
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P045 - HIGH DIMENSIONAL IMMUNE PHENOTYPING AND TRANSCRIPTIONAL ANALYSES REVEAL ROBUST RECOVERY OF VIABLE HUMAN IMMUNE AND EPITHELIAL CELLS FROM CRYOPRESERVED INTESTINAL TISSUE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P046 - HISTOLOGIC MEASURES OF MUCOSAL HEALING CORRELATE WITH ENDOSCOPIC MEASURES OF DISEASE ACTIVITY AT BASELINE AND FOLLOWING INDUCTION THERAPY WITH THE JANUS KINASE 1 INHIBITOR FILGOTINIB IN ACTIVE CROHN’S DISEASE: RESULTS FROM FITZROY STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P047 - HISTOLOGICAL AND ENDOSCOPIC HEALING AFTER QBECO TREATMENT IN AN OPEN-LABEL PHASE 2 STUDY IN PATIENTS WITH ULCERATIVE COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P048 - HISTORY OF CYTOMEGALOVIRUS COLITIS IS ASSOCIATED WITH POOR LONG-TERM OUTCOMES IN ADALIMUMAB THERAPY IN KOREAN PATIENTS WITH ULCERATIVE COLITIS: A HOSPITAL-BASED COHORT STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P049 - HYPERCALCEMIA DUE TO ISOLATED ELEVATION OF 1,25-DIHYDROXYVITAMIN D IN A PATIENT WITH CROHN’S DISEASE: CASE REPORT AND REVIEW OF LITERATURE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P050 - IBD CALL CENTER WORKFLOW CHANGES: IMPROVING PATIENT EXPERIENCE AND REDUCING ADMINISTRATIVE BURDEN
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P051 - IBD PATIENT COMPLIANCE WITH MOBILE AND WEARABLE TECHNOLOGIES AS TOOLS TO ASSESS QUALITY OF LIFE, SLEEP QUALITY AND PAIN
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P052 - IMMUNO-CHECKPOINT INHIBITOR INDUCED COLITIS IN A PATIENT WITH LUNG CANCER AND COLON METASTASIS TREATED WITH MESALAMINE: A CASE STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P053 - IMMUNO-CHECKPOINT INHIBITORS INDUCED COLITIS TREATED WITH MESALAMINE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P054 - IMPACT OF INFLAMMATORY BOWEL DISEASE ON PHYSICAL MOBILITY AND QUALITY OF LIFE: PHYSICIAN AND PATIENT PHYSICAL REHABILITATION PERSPECTIVES DIVERGE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P055 - IMPACT OF NEW BIOLOGIC AGENT APPROVAL FOR ULCERATIVE COLITIS ON TUMOR NECROSIS FACTOR INHIBITOR (TNF) PRESCRIBING: RESULTS FROM A NATIONAL PATIENT CHART AUDIT
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P056 - IMPLEMENTING MASS CYTOMETRY AS A TOOL FOR INFLAMMATORY BOWEL DISEASE RESEARCH
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P057 - IMPROVED QUALITY OF CARE AND QUALITY OF LIFE FOR IBD PATIENTS USING MOBILE BASED REMOTE MONITORING PLATFORM: A RANDOMIZED CONTROL TRIAL
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P058 - INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P059 - INDOLEAMINE 2,3-DIOXYGENASE 1 EXPRESSION PROMOTES EPITHELIAL SECRETORY CELL DIFFERENTIATION VIA ARYL HYDROCARBON RECEPTOR
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P060 - INFLAMMATION-ASSOCIATED COLONIC LYMPHATIC ARCHITECTURE DISRUPTION IS AMELIORATED BY IRISIN A CHRONIC RODENT MODEL OF IBD
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P061 - INFLAMMATORY BOWEL DISEASE SEVERITY INFLUENCES VITAMIN D MONITORING
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P062 - INTEGRIN ß7 DEFICIENCY RESULTS IN PAUCITY OF TERTIARY LYMPHOID TISSUES AND DECREASED LAMINA PROPRIA IGA+ B CELLS LEADING TO MICROBIOME DYSBIOSIS AND WORSE INFLAMMATION IN A MODEL OF CROHN’S-LIKE ILEITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P063 - INTERACTIONS OF GENETIC AND ENVIRONMENTAL FACTORS TRIGGER UNIQUE PPAR-GAMMA SIGNATURE IN PANETH CELLS IN CROHN'S DISEASE SUBJECTS AND RELEVANT MOUSE MODELS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P064 - INTERFERON-GAMMA INDUCED VASCULAR IMPAIRMENT CONTRIBUTES TO THE PATHOGENESIS OF INFLAMMATORY BOWEL DISEASES
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P065 - INTERNISTS’ PRACTICE AND PERCEPTIONS OF RESPONSIBILITY OF IBD-RELATED HEALTH MAINTENANCE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P066 - INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN'S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P067 - INVESTIGATION OF THE PRESENCE OF MYCOBACTERIUM AVIUM SSP. PARATUBERCULOSIS IN CHILDREN WITH CROHN DISEASE USING QUANTITATIVE DNA SEQUENCE-BASED APPROACHES
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P068 - LIPID PHOSPHATE PHOSPHATASE-3 (LPP3) DEFICIENCY INTENSIFIES INTESTINAL INFLAMMATION IN THE DSS MODEL OF ULCERATIVE COLITIS: ROLES OF LYSOPHOSPHATIDIC ACID AND LYMPHATIC/VASCULAR NETWORKS IN INFLAMMATORY GUT INJURY?
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P069 - LOW FAT DIET IMPROVES QUALITY OF LIFE AND CHANGES THE MICROBIOME IN A CATERED, CROSS-OVER DESIGN INTERVENTION OF UC PATIENTS WITH QUIESCENT DISEASE: RESULTS OF A PILOT STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P070 - MACROPHAGE-EXPRESSED ERBB4 PLAYS A PROTECTIVE ROLE IN THE ONSET AND RESOLUTION OF EXPERIMENTAL COLITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
Home
Sessions
Speakers
Exhibitors
Floor Plan
Tweet
Login
|
Back to top
ChirpE